NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
about
Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimensEarly investigational drugs for hearing loss.Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry.Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesAn expanding role for interleukin-1 blockade from gout to cancer.Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell deathCanakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians.NLRP3 Is Expressed in the Spiral Ganglion Neurons and Associated with Both Syndromic and Nonsyndromic Sensorineural Deafness.Treating inflammation by blocking interleukin-1 in humans.Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.Monogenic autoinflammatory diseases.CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease.Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.Challenges in diagnosing Muckle-Wells syndrome: identifying two distinct phenotypes.[Cryopyrin-associated periodic syndrome].Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).Nephrotic syndrome and AA amyloidosis revealing adult-onset cryopyrin-associated periodic syndrome.Overview of the IL-1 family in innate inflammation and acquired immunity.Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population.Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra: a case report and review of the literature.Cryopyrin-Associated Periodic Fever Syndrome and the Nervous SystemAnakinra Therapy for Non-cancer Inflammatory Diseases
P2860
Q33767097-0E43E6A1-55F3-41D6-874B-BC89C16DE2FAQ33847686-A4BECBB5-3820-45B4-91DE-E5E3988192B3Q34429717-2C2A3ACA-3AFD-4839-8642-A1D29B6A67A2Q35133812-332C6D7D-41ED-4B87-9951-5CEF1E0C63F3Q35219001-ACE3858F-8A57-4A51-BDB4-A1E8D83F1D95Q36816872-6DEE3277-DC68-4F34-B008-3A5F87000549Q36839612-A3DFA626-62EA-4BC4-820B-E51939B30B00Q37331996-D91B4D05-B35C-4AAA-9B53-B8BA3AF5A998Q37443618-1CBAE3E8-D3DA-44E1-9EB7-D40886DF8B22Q37636664-4DE51F1C-F56B-46B9-B380-3596486988C2Q37733733-C61E6200-98D9-4B06-B777-2BDC51519C37Q38211947-684591F1-6B4A-47E0-91CA-DE6DA599A22FQ38473823-D4F84DDE-7B95-4ED4-94AB-6AD7CE007FBDQ38542409-2FF7B7DE-B355-44F9-9DCE-0F92F54ADFF2Q38574807-55F52550-C506-48BA-9C9F-53DEC8766C5DQ40231494-B37AE54E-F38D-40FF-A809-6857DB2A5B22Q40289375-F5F9BF73-3CD0-4DB5-940C-65BAE8BA0624Q42217565-C2A73EEC-F7A4-4A4B-B497-88FDD97484E6Q44046103-F1EF734C-FD4B-49CF-B400-74DAD05745CDQ47285878-6E123C35-4BD2-43E7-9F50-C5645EA74FEBQ47795988-D055A69E-6760-42CD-9832-0666EE8EF14EQ49574128-7F6EC26B-DC92-4E3C-9F1C-0C3BFE2B841BQ58767090-C78921B0-6423-48C8-AF1D-5FE89E69A736Q59136398-DEA02A0A-A24F-4286-B02B-AD146C26E490
P2860
NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
NLRP3 E311K mutation in a larg ...... ype and response to treatment.
@ast
NLRP3 E311K mutation in a larg ...... ype and response to treatment.
@en
type
label
NLRP3 E311K mutation in a larg ...... ype and response to treatment.
@ast
NLRP3 E311K mutation in a larg ...... ype and response to treatment.
@en
prefLabel
NLRP3 E311K mutation in a larg ...... ype and response to treatment.
@ast
NLRP3 E311K mutation in a larg ...... ype and response to treatment.
@en
P2093
P2860
P356
P1476
NLRP3 E311K mutation in a larg ...... ype and response to treatment.
@en
P2093
Anja Bialkowski
Fabian Reess
Guenther E Dannecker
Ina Koetter
Jasmin B Kuemmerle-Deschner
Katharina Ummenhofer
Nikolay Tzaribachev
Peter Lohse
Silvia Koch
Susanne M Benseler
P2860
P2888
P356
10.1186/AR3526
P577
2011-12-06T00:00:00Z
P5875
P6179
1011368112